Navigation Links
Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
Date:7/16/2009

VANCOUVER, July 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) Long Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) designed for long lesions. At 38 mm, it is the longest available DES, providing doctors an option that can potentially reduce the number of stents used in more complex cases, simplifying procedures and reducing costs. It affords a more efficient treatment option for the estimated 8 to 10 percent(1) of patients with long lesions. Boston Scientific plans to launch the product in the U.S. next month. It received CE Mark approval in 2007.

"The TAXUS Liberte Long Stent offers physicians and patients distinct advantages compared to using two overlapping drug-eluting stents," said Mark Turco, M.D., FACC, FSCAI, Director of the Center for Cardiac Vascular Research at Washington Adventist Hospital, Takoma Park, Maryland. "In the ATLAS Long Lesion Trial, the 38 mm TAXUS Liberte Stent significantly reduced myocardial infarction when compared to the TAXUS(R) Express(R) Stent, making the TAXUS Liberte Long Stent an attractive option for interventional cardiologists faced with long, challenging lesions."

The TAXUS ATLAS Long Lesion Trial reported a significant 79 percent reduction in the rate of nine-month myocardial infarction for the TAXUS Liberte Long Stent as compared to the TAXUS Express Stent control (1.3% vs. 6.3%, p=0.026). At two years, the composite measure of cardiac death or myocardial infarction showed a significant 63 percent reduction for the TAXUS Liberte Long Stent compared to
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
2. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
3. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
4. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
5. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
6. Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
7. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
8. Angiotech announces date of annual general meeting of shareholders
9. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
10. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
11. Angiotech announces positive results from Bio-Seal(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Lexington,Kentucky and Queens, New York (PRWEB) October 02, ... is pleased to announce funding received to ... pathway in Alzheimer’s disease. A grant award from ... Institute on Aging (NIA), National Institutes of Health ... as Novel AD Therapeutics." The company also received ...
(Date:10/2/2014)... Arbor, Mich. (PRWEB) October 02, 2014 ... working with Hile Creative to refine its marketing approach. ... — MS Bioworks serves researchers in the biological sciences, ... MS Bioworks has already seen substantial growth over the ... engage with current customers, the company plans to launch ...
(Date:10/2/2014)... Schlieren, Switzerland and Morgantown, West Virginia (PRWEB) October ... Inc. (OTCQB: PRGB ) and InSphero AG jointly ... on mass spectrometry imaging of InSphero’s 3D InSight™ ... InSphero and hosted members of InSphero’s scientific team ... of the microtissues. Protea has since developed workflows ...
(Date:10/2/2014)... October 02, 2014 At a time when ... Products has introduced a new kind of squeeze aimed ... is the Scienceware® Squeeze Rite™ Wash Bottle , catalog ... position within the bottle reduces the waste of reagents, solutions ... those liquids. , “Easier to squeeze when compared to standard ...
Breaking Biology Technology:Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 2Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 3Hile Creative to Provide Copywriting and Graphic Design Services for MS Bioworks 2Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 2Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 3Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 4New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2
... device will help UK athletes reach the top of ... Sport, the UK,s high performance sports agency, has reached ... cutting edge technology developed by Argento Diagnostics to improve ... able to monitor various proteins which reveal details about ...
... their initial focus on national economic competitiveness, the nanotechnology ... have become increasingly collaborative, with nearly a quarter of ... Researchers from the two leading producers of nanotechnology ... become each nation,s most frequent international co-authors. Though ...
... Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic ... Los Angeles campus, today announced the execution of an ... of biological markers of mucosal healing in patients with ... by Dr. Jonathan Braun, Chair of the Department of ...
Cached Biology Technology:Medical science helps UK athletes reach peak performance 2Medical science helps UK athletes reach peak performance 3Web of international collaboration boosts worldwide nanotechnology research 2Web of international collaboration boosts worldwide nanotechnology research 3Web of international collaboration boosts worldwide nanotechnology research 4Prometheus Laboratories and UCLA Sign Agreement to Validate Biological Markers of Mucosal Healing in IBD 2
(Date:9/30/2014)... using marijuana, new research, involving mice and published in ... of Leukocyte Biology , suggests that just because ... That,s because a team of Italian scientists have found ... damage to the immune system. This damage may result ... multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis in ...
(Date:9/30/2014)... German . , ... situations such as exposure to predators. Researchers from the ... long-term study on different populations of great tits that ... temperature. High metabolic rates and low temperatures were associated ... were more likely to approach potential predators. , The ...
(Date:9/30/2014)... KONG , Sept. 30, 2014 Winners of ... Economist Events, Innovation Summit scheduled to take place at the JW ... the summit, the award winners will share their experiences and the ... who have made a proven innovation over the past decade, will ... the night before the summit. It will be the first ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Risky metabolism 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... of 12 companies selected for BOSS-U $497 million ... Army Biometrics Task Force has selected Raytheon Company ... services and support to enhance the ability of ... for biometric defense capabilities. The Biometrics Operations and ...
... of all Americans suffer from Obsessive-Compulsive Disorder (OCD). But when ... check your email every five minutes and mental illness? ... to understand and effectively treat OCD is to look at ... a program that allows us to videotape people that suffer ...
... "new" amino acid was added to the alphabet of 20 ... at Yale and the University of Tokyo have demonstrated how ... acids made its way into the menu for protein ... publication of the journal Nature . The rare ...
Cached Biology News:Raytheon Chosen to Help Provide Department of Defense Biometrics Operations and Support Services 2Biofeedback from the zoo 2'Fishy' clue helps establish how proteins evolve 2
Request Info...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... DNAzol Reagents are complete ready-to-use reagents for ... Reagent is specifically formulated for the isolation ... Reagent is specifically formulated for the isolation ... isolated with DNAzol Reagents can be used ...
Biology Products: